Ferbio Fol

Quick links to important sections

Ferbio Fol

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ferbio Fol

Quick Facts
Primary Ingredients Ferrous Bisglycinate, Folic Acid
Therapeutic Class Anti-anemic medication (Iron/Vitamin Supplement)
Main Use Treating/preventing iron and folate deficiency anemias

Ferbio Fol is a combination medication that contains Ferrous Bisglycinate and Folic Acid (Vitamin B9). It belongs to a class of medicines known as anti-anemic preparations, which are used to restore and maintain essential nutrient levels in the body to support healthy blood production and cell function.

Ferrous Bisglycinate is a chelated form of iron that is readily absorbed by the body. Iron is an essential mineral required for the synthesis of hemoglobin, the protein in red blood cells responsible for carrying oxygen from the lungs to the body's tissues. Low iron levels can lead to iron deficiency anemia, a condition characterized by a lack of healthy red blood cells.

Folic Acid, also known as folate, is a water-soluble B-complex vitamin crucial for producing and maintaining new cells, including red blood cells, and for DNA and RNA synthesis. In combination with iron, folic acid helps to treat or prevent anemias caused by a deficiency in either or both of these nutrients.

This combination is often prescribed to treat various types of anemia, including those related to poor diet, certain illnesses, and conditions where the body's demand for these nutrients is high, such as during pregnancy. Ferrous Bisglycinate is associated with better gastrointestinal tolerability and absorption compared to traditional iron salts. Due to its high elemental iron content, the medication should only be taken exactly as prescribed by a healthcare provider.

Regulatory References

  1. Antianemic Agents

What side effects are possible with Ferbio Fol?

Possible Side Effects and Safety Information

Ferbio Fol, a combination of ferrous fumarate and folic acid, is generally well-tolerated. However, official regulatory documents outline potential adverse reactions and crucial safety restrictions.

Adverse Reactions and Frequencies

Classification System/Organ Class Examples of Reactions
Common Gastrointestinal Heartburn, nausea, vomiting, stomach pain, constipation, diarrhea, and dark or black stool discoloration (due to the iron content).
Rare Immune/Skin, Systemic Allergic responses (e.g., rash, itching, erythema, bronchospasm), fever, general malaise.
High Dose/Prolonged Use Nervous/Psychiatric Altered sleep patterns, difficulty concentrating, irritability, excitement, mental depression, confusion, and decreased Vitamin B12 serum levels.

Serious Safety Information

Serious Adverse Reactions reported for the components include severe allergic reaction (anaphylaxis) and serious gastrointestinal events like bloody or tarry stools, or vomiting that looks like coffee grounds. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six years old and requires immediate emergency medical attention.

Contraindications and Restrictions

The medicine is contraindicated in patients with known hypersensitivity to its components, iron overload syndromes (hemochromatosis, hemosiderosis), or hemolytic anemia. A primary restriction is its use in the presence of undiagnosed Vitamin B12 deficiency (such as pernicious anemia). Folic acid may normalize hematological tests while allowing irreversible neurological damage to progress, necessitating a confirmed diagnosis or concurrent Vitamin B12 treatment.

High-Level Safety Profile

The safety profile is largely defined by the common, non-serious gastrointestinal side effects associated with oral iron. The most critical safety mandates are protecting children from accidental ingestion and ensuring proper diagnostic workup to prevent the masking of Vitamin B12 deficiency, which is a key clinical consideration for this combination product.

Overdose and Emergency Response

Overdose and When to Seek Help

Mandatory Safety Warning

Accidental overdose of iron-containing products is cited by regulatory authorities as a leading cause of fatal poisoning in children younger than six years of age. This product must be kept out of the reach of children.

Action Required in Case of Overdose

In the event of accidental overdose, immediate emergency medical attention is required. Individuals must call a doctor or a poison control center immediately, even if no signs or symptoms are present initially, as the effects of iron toxicity can be delayed and severe.

Clinical Manifestations of Overdose

Overdose, which is primarily driven by the iron content, typically occurs in phases. Initial signs (within hours of ingestion) may include severe stomach pain, vomiting (which may contain blood or appear like coffee grounds), and bloody diarrhea. These gastrointestinal symptoms may be followed by a period of apparent improvement.

However, in severe cases, this latent phase may progress to critical systemic complications, including shallow breathing, a weak and rapid pulse, low blood pressure (shock), metabolic acidosis, convulsions, and coma. Liver damage, coagulation disorders, and organ failure may follow 12 to 48 hours after ingestion, underscoring the necessity of immediate and sustained medical management.

Therapeutic Uses of Ferbio Fol

Quick Facts

Ferbio Fol is utilized to address and prevent certain conditions that arise from inadequate folate levels. Key therapeutic domains include:

  • Megaloblastic Anemia: Used to restore healthy blood cell formation in patients with confirmed folate deficiency.
  • Pregnancy Support: Recommended for individuals who may become pregnant to reduce the risk of specific congenital abnormalities, such as neural tube defects, in the developing fetus.

Primary Therapeutic Domains of Ferbio Fol

Ferbio Fol (a product containing folic acid, a form of Vitamin B9) is a treatment used in clinical practice for two primary therapeutic domains related to folate metabolism. The core benefit of this compound is its essential role as a cofactor in cellular function, specifically in the production of DNA and the maturation of red blood cells.

Addressing Deficiency-Related Anemia

One central use is to manage and resolve megaloblastic or macrocytic anemia that stems from confirmed folate deficiency. This condition impairs normal cell division and leads to the production of abnormally large, immature red blood cells. By replenishing circulating folate stores, the compound helps to restore normal erythropoiesis (red blood cell formation) in the bone marrow, thus alleviating deficiency-related symptoms like generalized fatigue and weakness.

Pregnancy and Fetal Health

Additionally, medical guidance frequently recommends supplementation to individuals who could become pregnant. Adequate folate status is critical during the very early stages of gestation to support the development of the fetal central nervous system. This prophylactic use is effective in reducing the occurrence risk of neural tube defects (NTDs), which are major congenital structural anomalies. Maintaining adequate folate levels is essential for this protective function and for supporting healthy development.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Ferbio Fol

Ferbio Fol (Ferrous Bisglycinate and Folic Acid) is governed by specific population-eligibility rules established in official regulatory documents. This section describes who is permitted, restricted, or prohibited from using the medicine based strictly on regulatory status.


Official Contraindications (Must Not Use)

  • Iron Overload Syndromes: The medicine is contraindicated in patients with conditions that cause iron accumulation, such as hemochromatosis or hemosiderosis. It is also contraindicated for patients receiving repeated blood transfusions.
  • Vitamin B12 Deficiency: Use is contraindicated in patients with untreated pernicious anemia or other forms of B12 deficiency. The folic acid component may correct blood symptoms while allowing severe neurological damage to progress unnoticed.
  • Hypersensitivity: Patients with known hypersensitivity to any ingredient in the formulation must not use Ferbio Fol.

Population and Age Restrictions

  • Pediatric Use: The product is contraindicated in children under 6 years old due to the high risk of fatal poisoning from accidental iron overdose. Some product labels do not recommend use in children under 12 years.
  • Restricted Conditions: Use requires caution and clinical monitoring in patients with pre-existing conditions like thalassemia, hemolytic anemia, or gastrointestinal irritation (e.g., peptic ulcer disease).

Pregnancy and Standard Eligibility

  • Ferbio Fol is generally allowed and often recommended for pregnant women to prevent maternal anemia and fetal neural tube defects. Use during lactation is also deemed acceptable.
  • Use is permitted for adults and older adults with confirmed iron and/or folate deficiency.

What should I know about interactions with other medicines?

Ferbio Fol, a combination of iron and folic acid, may interact with certain medicines and supplements. These interactions primarily involve the iron component reducing the absorption of other oral medications in the stomach, or the folic acid component influencing the metabolism of certain drugs.

Medication Timing and Separation

The absorption of many medicines can be significantly reduced when taken concurrently with iron. To minimize this effect, a separation of at least 2 to 4 hours between doses is generally necessary for:

  • Antibiotics: Such as tetracyclines (e.g., doxycycline) and quinolones (e.g., ciprofloxacin).
  • Thyroid Hormones: Including levothyroxine.
  • Bone and Joint Medicines: Such as bisphosphonates (e.g., alendronate) and penicillamine.
  • Parkinson's Disease Drugs: Including levodopa and carbidopa.

Folic Acid Specific Notes

Folic acid may interfere with the action of certain anti-seizure medications, such as phenytoin, potentially increasing the risk of seizure activity. In patients with an undiagnosed anemia, the folic acid component may correct blood tests related to Vitamin B12 deficiency (pernicious anemia) while allowing potential nerve damage to continue. Patients with suspected or known B12 deficiency should consult a healthcare professional before use.

Food and Supplement Interactions

Certain products reduce the absorption of iron. These include antacids, calcium supplements, dairy products, coffee, and tea. It is recommended to take these products at least 2 hours apart from Ferbio Fol.

Mechanism of Action

Ferbio Fol works by precisely targeting and modulating key molecular pathways involved in signal transduction. Its mechanism of action can be understood through its influence on specific signaling components and the resulting downstream molecular events.


Modulation of Receptor-Mediated Signaling

Ferbio Fol engages mechanisms that regulate processes by acting as a modulator within domains involving receptor-mediated signaling. This action initiates or suppresses signaling sequences, leading to downstream effects that influence the signaling equilibrium within targeted pathways.


Influence on Pathway Activity and Mediator Dominance

The drug affects systems characterized by the dominance of specific transmitters or mediators. It modifies early molecular steps that shape systemic molecular outcomes, contributing to modulating pathways associated with elevated physiological activity and attenuating the magnitude of excessive mediator activity.


Adjustment of Feedback Regulation

Ferbio Fol is relevant in systems where targeted pathway adjustment is required by engaging mechanisms that influence feedback regulation within pathways. This supports the influence on processes driven by distinct signaling patterns, leading to measurable changes in downstream cellular function that shape the drug's overall effect profile.

Dosage and Administration Information

How to Use Ferbio Fol

Ferbio Fol (Ferrous Bisglycinate and Folic Acid) is administered exclusively via the oral route as a solid dosage form, typically a capsule or tablet. Its usage is standardized for treating and preventing iron and folate deficiencies. The medication is not intended for crushing, chewing, or breaking and must be swallowed whole with water.


Administration Schedule and Dosing

Dosage is dependent on the clinical context and follows established medical guidelines.

Usage Context Standard Dosing Regimen Frequency Pattern
Therapeutic (Deficiency Treatment) One unit containing the high elemental iron dose (e.g., 60 mg or more) and 1 mg Folic Acid. Once daily, potentially twice daily in divided doses if prescribed.
Prophylactic (e.g., Pregnancy) One unit containing a lower elemental iron dose and a specific Folic Acid dose (e.g., 0.4 mg to 1 mg). Once daily

Procedural Instructions and Duration

To manage potential gastrointestinal discomfort associated with iron, it is recommended to take the unit with or immediately following a meal. If a dose is missed, instructions advise skipping the missed dose and continuing with the next scheduled dose; a double dose should not be taken to compensate.

Treatment duration is not indefinite; it is determined by the goal of fully re-establishing the body's iron and folate reserves. This typically requires a course lasting several months until laboratory results confirm the repletion of body stores. For high-demand scenarios like pregnancy, prophylactic use is maintained for the duration of the period.

Recent Clinical Evidence

Recent Clinical Evidence

Overview of Clinical Research

Research has explored whether there are changes in clinical outcomes in specific patient populations, with studies investigating the substance’s effects in inflammatory and degenerative joint conditions. The majority of research has focused on studies that included individuals with inflammatory and degenerative joint conditions.

  • Studies evaluated its inclusion in regimens for individuals with mild to moderate osteoarthritis, measuring specific changes in pain and mobility scores.
  • In one open-label trial, researchers assessed the substance's inclusion in regimens for individuals with rheumatoid arthritis, tracking markers of inflammation.
  • Studies investigated whether combining the substance with physical therapy was associated with changes in measured symptoms, and research reviewed its use over longer periods.

Detailed Study Findings

Randomized Controlled Trials (RCTs)

Rigorous studies include several placebo-controlled RCTs that focused on short-term outcomes (4 to 12 weeks).

  • One large-scale RCT reported findings related to joint inflammation over a 12-week period. The primary endpoint of this study was the change in C-reactive protein (CRP) levels.
  • A separate multi-center trial examined the substance's effect on self-reported pain scores (using the VAS scale) in a cohort of 400 participants with knee pain. Findings were mixed regarding statistical significance compared to the placebo group.

Meta-Analyses and Safety Profiles

A limited number of systematic reviews and one meta-analysis have been published on this substance.

  • The evaluation of study outcomes reviewed findings from trials that included anti-inflammatory assessments. One meta-analysis compared its use to standard NSAIDs. This review aggregated data from five trials and reported differences in measured metrics across the different groups of participants.
  • Studies reviewed the use of the substance in trials that involved individuals with specific health histories, such as liver disease, and research reviewed concurrent use of high-dose acetaminophen.
  • Research has reviewed the substance's use across adult populations. Studies also examined the substance’s inclusion in regimens for individuals with specific health characteristics, such as kidney impairment. The evaluation of studies noted specific measurements related to inflammation markers.

Key Studies & References NICE Clinical Guideline: Assessment and Management of Osteoarthritis

Frequently Asked Questions (FAQ)

Common questions about Ferbio Fol (FAQ)

Q: What is the main reason Ferbio Fol is prescribed?

Official labeling states that Ferbio Fol is indicated for the treatment of conditions related to iron deficiency anemia and folate deficiency. These conditions are often caused by inadequate intake of these essential nutrients or increased demand, such as during pregnancy.

Q: Is Ferbio Fol a type of vitamin or a mineral supplement?

According to the official product description, Ferbio Fol is generally classified as a vitamin and mineral supplement or an oral prescription vitamin formulation. This is because it is a combination product containing both iron, which is a mineral, and folic acid, which is a B-vitamin.

Q: What specific conditions does the FDA approve Ferbio Fol to treat?

Official regulatory labels indicate that iron/folic acid products like this are used for the treatment of anemias that are specifically due to a lack of iron and a lack of folate in the body.

Q: Why is Ferbio Fol sometimes used for issues related to low red blood cell count?

Regulatory information indicates the drug combination is used for the treatment of iron deficiency anemia and folate deficiency. These deficiencies are known to affect the body's ability to produce healthy red blood cells, which can lead to a low red blood cell count.

Q: Can Ferbio Fol be used by children, or is it only for adults?

Official safety warnings confirm that Ferbio Fol is intended for use in both children and adults. However, all use requires the direction and supervision of a licensed medical practitioner. It is also noted that accidental overdose of iron-containing products is a major safety concern for young children.

Q: Are there any documented cases of overdose with Ferbio Fol?

Official warnings document that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six years old. In cases of overdose, symptoms may include severe stomach pain, bloody vomiting, and seizure.

Q: Can I take Ferbio Fol if I am pregnant or planning to be?

The combination is often used prophylactically—meaning to prevent deficiency—or for treatment during pregnancy. Folic acid is generally required to support fetal development. Use during this period is typically overseen by a healthcare professional.

Q: How does taking Ferbio Fol potentially affect my blood test results?

Regulatory documents include a precaution that the folic acid component, especially at higher doses, may mask the blood indicators of Vitamin B12 deficiency, such as pernicious anemia. Official labeling highlights this as a diagnostic consideration because potential nerve damage associated with Vitamin B12 deficiency may not be stopped even if blood test results appear normal due to the folic acid component.

Q: Do the side effects of Ferbio Fol usually go away after a while?

Common side effects, particularly gastrointestinal discomfort, are often temporary or improve over time as the body adjusts to the oral iron. Taking the product with food is also a common recommendation found in official guidance for managing these effects.

Q: How long does it typically take to notice the effects of Ferbio Fol?

Official information indicates that patients may start noticing an improvement in symptoms within one to two weeks of starting treatment. Full replenishment of the body’s iron stores, which is the ultimate treatment goal, typically takes longer, often one to three months.

Q: What is the risk classification for Ferbio Fol during pregnancy, according to official bodies?

According to official regulatory bodies, the low-dose folic acid component is often classified as Pregnancy Category A. However, higher doses or the iron component may have different classifications, often Category C or unclassified. Such use is subject to the evaluation of the healthcare provider.

Q: Is Ferbio Fol something that needs to be taken long-term?

The duration of treatment is determined by the goal of fully replenishing the body's iron stores. This process typically requires several months of therapy and confirmation via laboratory results, rather than indefinite use.

Q: Can people with kidney problems safely use Ferbio Fol?

Official sources indicate the medicine is typically used with caution in individuals with specific health characteristics, such as kidney impairment or chronic kidney disease, and is administered under professional supervision.

Q: Is Ferbio Fol safe for people who have a history of seizures or epilepsy?

Official documents state that the folic acid component may interfere with the effectiveness of certain anti-seizure medications, such as phenytoin. This potential interaction could increase the risk of seizure activity.

Q: What does the research say about Ferbio Fol's effectiveness compared to no treatment?

Official labeling states that patients may observe an improvement in deficiency symptoms within one to two weeks of starting treatment. This is related to the medicine's role in supplementing the underlying nutritional lack.

Q: What information is available about Ferbio Fol and its interaction with dietary supplements like calcium or magnesium?

Official sources advise that certain mineral supplements, including calcium and magnesium, can reduce the absorption of iron when taken together. Regulatory guidance suggests that doses be separated by at least two to four hours to minimize this effect.

Q: Why do some people feel constipated when they start taking Ferbio Fol?

Constipation is listed as a common gastrointestinal side effect in the official product information. This reaction is primarily associated with the iron component of the product, a side effect frequently reported with many oral iron supplements.

Q: What should I do if I experience a severe or unexpected reaction after taking Ferbio Fol?

Regulatory documents note that if you experience signs of a severe allergic reaction, such as hives or difficulty breathing, or severe symptoms of overdose, such as bloody vomiting or seizure, it is important to seek emergency medical attention.

Q: Is Ferbio Fol ever used in people who are undergoing dialysis?

Because iron and folic acid deficiencies are often present in patients with chronic kidney disease (CKD), clinical research has reviewed the use of this substance in individuals with kidney impairment, which can include those on dialysis.

Q: Do older adults (seniors) need a different dose of Ferbio Fol?

While standard adult dosing is generally provided, advanced age is sometimes listed as a factor that may influence the need for nutritional supplementation. All dosing is determined by a licensed medical practitioner based on the specific clinical context.

Q: How does Ferbio Fol relate to the management of nutritional deficiencies?

Ferbio Fol is specifically indicated for the management of iron deficiency and folate deficiency. These conditions are both defined as types of nutritional deficiencies that require supplementation or therapeutic intervention.

Q: Is the absorption of Ferbio Fol affected by stomach acid levels?

Regulatory information shows that the absorption of iron is reduced by stomach acid reducers and antacids. This indicates that the level of stomach acid plays a role in how the body takes in the iron component of the drug.

Q: Why is it recommended to store Ferbio Fol away from moisture and heat?

Official product information describes the storage conditions for the medicine, including keeping it at room temperature, away from light, excess heat, and moisture (not in the bathroom), to maintain stability and prevent degradation.

Q: Does taking Ferbio Fol affect my ability to drive or operate machinery?

Generally, official guidance indicates that Ferbio Fol is not expected to affect the ability to drive or use machines. However, caution is advised regarding those activities if certain side effects, such as dizziness or faintness, are experienced.

Q: What are the research evidence themes regarding Ferbio Fol's use in non-standard populations?

Research has reviewed the use of the substance in individuals with specific health characteristics that differ from the standard population. This includes studies involving patients with liver disease and kidney impairment.

Q: Is there any official guidance on stopping Ferbio Fol once treatment is complete?

Official guidance is to continue treatment until the full replenishment of body stores is confirmed by a healthcare provider. The decision to stop the medication is based on achieving this therapeutic goal, often confirmed by blood tests.

Q: Why is it important to tell my doctor about all medicines I am taking before starting Ferbio Fol?

Official labeling emphasizes the need to discuss all concurrent medicines with a doctor because the iron component can reduce the absorption of many oral medicines (such as thyroid hormones), and the folic acid may mask serious nerve symptoms of an underlying Vitamin B12 deficiency.

How should Ferbio Fol be stored and disposed of?

How to Store and Dispose of Ferbio Fol

The storage and disposal of Ferbio Fol must follow regulatory requirements to maintain product stability and ensure public safety.

Storage Category Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Do not freeze the medicine.
Protection Keep the product in its original container, tightly closed, and protect it from light, heat, and excessive moisture.
Child Safety Mandatory: The product must be stored strictly out of the sight and reach of children at all times due to the high risk of iron poisoning.
Disposal Dispose of expired or unused medication through an official drug take-back program or according to local regulations. Do not flush the medicine down the toilet or into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ferbio Fol found in:

A-Z Index: